347 related articles for article (PubMed ID: 9409302)
21. The molecular basis of familial hypercholesterolemia in the Czech Republic: spectrum of LDLR mutations and genotype-phenotype correlations.
Tichý L; Freiberger T; Zapletalová P; Soška V; Ravčuková B; Fajkusová L
Atherosclerosis; 2012 Aug; 223(2):401-8. PubMed ID: 22698793
[TBL] [Abstract][Full Text] [Related]
22. Stanol ester margarine alone and with simvastatin lowers serum cholesterol in families with familial hypercholesterolemia caused by the FH-North Karelia mutation.
Vuorio AF; Gylling H; Turtola H; Kontula K; Ketonen P; Miettinen TA
Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):500-6. PubMed ID: 10669649
[TBL] [Abstract][Full Text] [Related]
23. Familial hypercholesterolaemia in Finland: common, rare and mild mutations of the LDL receptor and their clinical consequences. Finnish FH-group.
Vuorio AF; Aalto-Setälä K; Koivisto UM; Turtola H; Nissen H; Kovanen PT; Miettinen TA; Gylling H; Oksanen H; Kontula K;
Ann Med; 2001 Sep; 33(6):410-21. PubMed ID: 11585102
[TBL] [Abstract][Full Text] [Related]
24. Fh-Souassi: a founder frameshift mutation in exon 10 of the LDL-receptor gene, associated with a mild phenotype in Tunisian families.
Slimane MN; Lestavel S; Sun X; Maatouk F; Soutar AK; Ben Farhat MH; Clavey V; Benlian P; Hammami M
Atherosclerosis; 2001 Feb; 154(3):557-65. PubMed ID: 11257256
[TBL] [Abstract][Full Text] [Related]
25. Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolaemia.
Miltiadous G; Xenophontos S; Bairaktari E; Ganotakis M; Cariolou M; Elisaf M
Pharmacogenet Genomics; 2005 Apr; 15(4):219-25. PubMed ID: 15864114
[TBL] [Abstract][Full Text] [Related]
26. Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolemia.
Miserez AR; Keller U
Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1719-29. PubMed ID: 7583549
[TBL] [Abstract][Full Text] [Related]
27. Post mortem molecularly defined familial hypercholesterolemia and sudden cardiac death of young men.
Vuorio AF; Kontula K; Turtola H; Sajantila A
Forensic Sci Int; 1999 Dec; 106(2):87-92. PubMed ID: 10664894
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin-converting enzyme DD genotype and cardiovascular disease in heterozygous familial hypercholesterolemia.
O'Malley JP; Maslen CL; Illingworth DR
Circulation; 1998 May; 97(18):1780-3. PubMed ID: 9603531
[TBL] [Abstract][Full Text] [Related]
29. A novel single base deletion in the LDLR gene (211delG): Effect on serum lipid profiles and the influence of other genetic polymorphisms in the ACE, APOE and APOB genes.
Ward AJ; O'Kane M; Nicholls DP; Young IS; Nevin NC; Graham CA
Atherosclerosis; 1996 Feb; 120(1-2):83-91. PubMed ID: 8645375
[TBL] [Abstract][Full Text] [Related]
30. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
Grenkowitz T; Kassner U; Wühle-Demuth M; Salewsky B; Rosada A; Zemojtel T; Hopfenmüller W; Isermann B; Borucki K; Heigl F; Laufs U; Wagner S; Kleber ME; Binner P; März W; Steinhagen-Thiessen E; Demuth I
Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133
[TBL] [Abstract][Full Text] [Related]
31. Recent origin and spread of a common Lithuanian mutation, G197del LDLR, causing familial hypercholesterolemia: positive selection is not always necessary to account for disease incidence among Ashkenazi Jews.
Durst R; Colombo R; Shpitzen S; Avi LB; Friedlander Y; Wexler R; Raal FJ; Marais DA; Defesche JC; Mandelshtam MY; Kotze MJ; Leitersdorf E; Meiner V
Am J Hum Genet; 2001 May; 68(5):1172-88. PubMed ID: 11309683
[TBL] [Abstract][Full Text] [Related]
32. Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approach.
Versmissen J; Oosterveer DM; Yazdanpanah M; Dehghan A; Hólm H; Erdman J; Aulchenko YS; Thorleifsson G; Schunkert H; Huijgen R; Vongpromek R; Uitterlinden AG; Defesche JC; van Duijn CM; Mulder M; Dadd T; Karlsson HD; Ordovas J; Kindt I; Jarman A; Hofman A; van Vark-van der Zee L; Blommesteijn-Touw AC; Kwekkeboom J; Liem AH; van der Ouderaa FJ; Calandra S; Bertolini S; Averna M; Langslet G; Ose L; Ros E; Almagro F; de Leeuw PW; Civeira F; Masana L; Pintó X; Simoons ML; Schinkel AF; Green MR; Zwinderman AH; Johnson KJ; Schaefer A; Neil A; Witteman JC; Humphries SE; Kastelein JJ; Sijbrands EJ
Eur J Hum Genet; 2015 Mar; 23(3):381-7. PubMed ID: 24916650
[TBL] [Abstract][Full Text] [Related]
33. Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation.
Ferrières J; Lambert J; Lussier-Cacan S; Davignon J
Circulation; 1995 Aug; 92(3):290-5. PubMed ID: 7634440
[TBL] [Abstract][Full Text] [Related]
34. How To Identify Familial Premature Myocardial Infarction: Comparing Approaches To Identify Familial Hypercholesterolemia.
Beheshti S; Madsen CM; Varbo A; Nordestgaard BG
J Clin Endocrinol Metab; 2019 Jul; 104(7):2657-2667. PubMed ID: 30753598
[TBL] [Abstract][Full Text] [Related]
35. Relationship of Familial Hypercholesterolemia and High Low-Density Lipoprotein Cholesterol to Ischemic Stroke: Copenhagen General Population Study.
Beheshti S; Madsen CM; Varbo A; Benn M; Nordestgaard BG
Circulation; 2018 Aug; 138(6):578-589. PubMed ID: 29593013
[TBL] [Abstract][Full Text] [Related]
36. Contribution of receptor negative versus receptor defective mutations in the LDL-receptor gene to angiographically assessed coronary artery disease among young (25-49 years) versus middle-aged (50-64 years) men.
Gaudet D; Vohl MC; Couture P; Moorjani S; Tremblay G; Perron P; Gagné C; Després JP
Atherosclerosis; 1999 Mar; 143(1):153-61. PubMed ID: 10208490
[TBL] [Abstract][Full Text] [Related]
37. Variable expression and penetrance in Portuguese families with Familial Hypercholesterolemia with mild phenotype.
Gaspar IM; Gaspar A
Atheroscler Suppl; 2019 Mar; 36():28-30. PubMed ID: 30876530
[TBL] [Abstract][Full Text] [Related]
38. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
[TBL] [Abstract][Full Text] [Related]
39. Determinants of lipid level variability in French-Canadian children with familial hypercholesterolemia.
Lambert M; Assouline L; Feoli-Fonseca JC; Brun N; Delvin EE; Lévy E
Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):979-84. PubMed ID: 11397707
[TBL] [Abstract][Full Text] [Related]
40. Low frequency of the common Norwegian and Finnish LDL-receptor mutations in Swedish patients with familial hypercholesterolaemia.
Lind S; Eriksson M; Rystedt E; Wiklund O; Angelin B; Eggertsen G
J Intern Med; 1998 Jul; 244(1):19-25. PubMed ID: 9698020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
